Colon cancer study uses 'gene chip' technology

May 13, 2001

CLEVELAND -- Why does colon cancer recur after surgery for some people, but not for others? Researchers at Case Western Reserve University's School of Medicine and University Hospitals of Cleveland will seek the answer in a study using DNA microarray or "gene chip" technology.

The study -- "Gene Expression Signature of Colon Cancers that Metastasize" -- has the support of a $6.7 million grant from the National Institutes of Health for a four-and-a-half year period.

Researchers will use this new technology to analyze human tissue for changes in the expression of up to 40,000 different genes in colon cancers that were cured by surgery. Researchers then compare their results with cancers that spread after surgery and caused death.

"The hope of this project is to find the key genes that are responsible for causing colon cancers to spread and metastasize, and that could be targets for new anticolon cancer drugs," said Sanford Markowitz, the study's principal investigator.

"The aim is to benefit our patients with colon cancer, and to advance our basic understanding of the problem of cancer metastases," he said. "This project represents the fruits of being able to apply cutting edge cancer genetics to a major human disease, and of joining unique opportunities created by the collaboration of a world class medical school and world class hospital."
Markowitz is an associate investigator of the Howard Hughes Medical Institute and the Ingalls Professor of Cancer Genetics at CWRU.

Key collaborators include Joseph Willis, CWRU assistant professor in the UHC Department of Pathology; and Sunil Rao, assistant professor, and Sylvan Green, professor, both in CWRU's Department of Epidemiology and Biostatistics.

Support for this project also comes through developmental funds from the Ohio Board of Regents and developmental funds from the Ireland Cancer Center.

Case Western Reserve University

Related Colon Cancer Articles from Brightsurf:

New prognostic markers for colon cancer identified
The study recently published by MedUni Vienna and collaborative partners nominates ILSs as novel prognostic players orchestrating the pathobiology of metastatic colorectal cancer.

Turning colon cancer cells around
Using a modified natural substance along with current approaches could improve colon cancer treatment, according to findings by University of California, Irvine biologists.

Uncovering the pathway to colon cancer
The hidden world of genetic changes, or mutations, in healthy colon tissue has been uncovered by scientists at the Wellcome Sanger Institute and their collaborators.

Colon cancer growth reduced by exercise
Exercise may play a role in reducing the growth of colon cancer cells according to new research published in The Journal of Physiology.

Towards a better understanding of how colon cancer develops and progresses
Researchers from the University of Luxembourg have discovered a molecular mechanism that is responsible for the spread of cancer cells in the body and the development of metastases in patients with colon cancer.

New target protein for colon cancer identified
Researchers at Boston University School of Medicine (BUSM) have identified a new potential target protein (c-Cbl) they believe can help further the understanding of colon cancer and ultimately survival of patients with the disease.

Colon cancer -- Targeting tumor cell plasticity
Cell type switch helps colon cancer evade treatment, a study suggests.

A bacterial duo linked to colon cancer
Scientists have identified a combination of bacteria that appears to increase the risk of colon cancer.

New model could speed up colon cancer research
Using the CRISPR gene editing system, MIT researchers have shown they can generate colon tumors in mice that very closely resemble human colon tumors, an advance that should allow scientists to learn more about how the disease progresses and also help them test potential new drugs.

Are dialysis patients being over-screened for colon cancer?
Colonoscopies are being performed more often on healthier dialysis patients than on those with more limited life expectancies; however, overall, dialysis patients are being screened at a much higher rate relative to their life expectancy than their counterparts without kidney failure.

Read More: Colon Cancer News and Colon Cancer Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to